GSK (NYSE: GSK) announced new data for its shingles candidate vaccine Shingrix, at the Infectious Disease Week (IDWeek) scientific conference ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE